MedTrace Logo

Personalized Disease Prevention

NCT05463887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 721

Last updated 2026-03-02

No results posted yet for this study

Summary

This study will evaluate whether patients and their providers benefit from an evidence-based decision tool to help prioritize preventive (and select chronic disease management) services based on their potential to improve quality-adjusted life expectancy, individualized for patient risk factors. The study seeks to enroll 600 patients and 60 primary care providers. Half of providers will be assigned to an intervention to utilize the decision tool with approximately 10 high-priority patients each (patients of particular interest to the research study, on whom follow-up outcomes will be collected), and half will be assigned to usual care.

Surveys will be administered at baseline and approximately 6 months later; electronic health records data on preventive service utilization will be collected; and optional qualitative interviews may be conducted.

Conditions

  • Primary Prevention
  • Healthy Aging
  • Quality of Life
  • Decision Support Techniques

Interventions

BEHAVIORAL

Individualized preventive care recommendations (decision tool)

Providers will receive individualized preventive care recommendations (decision tool) for eligible patients, and discuss them with patients using shared decision-making

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Glen Taksler

    lead OTHER

Principal Investigators

  • Glen Taksler, PhD · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-05
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05463887 on ClinicalTrials.gov